These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 2510772

  • 1. Comparative evaluation of cefuroxime axetil and cefaclor for treatment of acute bacterial maxillary sinusitis.
    Sydnor A, Gwaltney JM, Cocchetto DM, Scheld WM.
    Arch Otolaryngol Head Neck Surg; 1989 Dec; 115(12):1430-3. PubMed ID: 2510772
    [Abstract] [Full Text] [Related]

  • 2. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis.
    Camacho AE, Cobo R, Otte J, Spector SL, Lerner CJ, Garrison NA, Miniti A, Mydlow PK, Giguere GC, Collins JJ.
    Am J Med; 1992 Sep; 93(3):271-6. PubMed ID: 1524078
    [Abstract] [Full Text] [Related]

  • 3. Cefuroxime axetil in the treatment of sinusitis. A review.
    Pakes GE, Graham JA, Rauch AM, Collins JJ.
    Arch Fam Med; 1994 Feb; 3(2):165-75. PubMed ID: 7994439
    [Abstract] [Full Text] [Related]

  • 4. Ciprofloxacin versus cefuroxime axetil in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group.
    Johnson PA, Rodriguez HP, Wazen JJ, Huck W, Shan M, Tosiello R, Heyd A, Echols RM.
    J Otolaryngol; 1999 Feb; 28(1):3-12. PubMed ID: 10077777
    [Abstract] [Full Text] [Related]

  • 5. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with secondary bacterial infections of acute bronchitis.
    Henry D, Ruoff GE, Rhudy J, Puopolo A, Drehobl M, Schoenberger J, Giguere G, Collins JJ.
    Clin Ther; 1995 Feb; 17(5):861-74. PubMed ID: 8595638
    [Abstract] [Full Text] [Related]

  • 6. Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.
    Schleupner CJ, Anthony WC, Tan J, File TM, Lifland P, Craig W, Vogelman B.
    Arch Intern Med; 1988 Feb; 148(2):343-8. PubMed ID: 3277562
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults.
    Siegert R, Berg O, Gehanno P, Leiberman A, Martinkenas JL, Nikolaidis P, Arvis P, Alefelder M, Reimnitz P.
    Eur Arch Otorhinolaryngol; 2003 Apr; 260(4):186-94. PubMed ID: 12709801
    [Abstract] [Full Text] [Related]

  • 8. Treatment of otitis media with cefuroxime axetil.
    Aronovitz GH.
    South Med J; 1988 Aug; 81(8):978-80. PubMed ID: 3043692
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
    Henry D, Ruoff GE, Rhudy J, Puopolo A, Drehobl M, Schoenberger J, Giguere G, Collins JJ.
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2528-34. PubMed ID: 8585739
    [Abstract] [Full Text] [Related]

  • 10. Cefuroxime axetil in the treatment of cutaneous infections.
    Parish LC, Cocchetto DM, Werner K, Jungkind DL, Witkowski J.
    Int J Dermatol; 1987 Nov; 26(6):389-93. PubMed ID: 3305394
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of cefuroxime-axetil in the treatment of acute sinusitis in adults. Comparative study with cefaclor].
    Freche C, Fombeur JP, Pappo M.
    Therapie; 1988 Nov; 43 Suppl 4():365-8. PubMed ID: 3222778
    [No Abstract] [Full Text] [Related]

  • 12. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin.
    Dagan R, Abramson O, Leibovitz E, Lang R, Goshen S, Greenberg D, Yagupsky P, Leiberman A, Fliss DM.
    Pediatr Infect Dis J; 1996 Nov; 15(11):980-5. PubMed ID: 8933545
    [Abstract] [Full Text] [Related]

  • 13. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
    Perry CM, Brogden RN.
    Drugs; 1996 Jul; 52(1):125-58. PubMed ID: 8799689
    [Abstract] [Full Text] [Related]

  • 14. A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group.
    Siegert R, Gehanno P, Nikolaidis P, Bagger-Sjöbäck D, Ibanez JM, Hampel B, Sommerauer B.
    Respir Med; 2000 Apr; 94(4):337-44. PubMed ID: 10845431
    [Abstract] [Full Text] [Related]

  • 15. Comparative study of cefuroxime axetil suspension and amoxycillin syrup in the treatment of acute otitis media in general practice.
    Brodie DP, Griggs JV, Cunningham K.
    J Int Med Res; 1990 Apr; 18(3):235-9. PubMed ID: 2113874
    [Abstract] [Full Text] [Related]

  • 16. Bacteriological efficacy of 5-day therapy with telithromycin in acute maxillary sinusitis.
    Buchanan P, Roos K, Tellier G, Rangaraju M, Leroy B.
    Int J Antimicrob Agents; 2005 Mar; 25(3):237-46. PubMed ID: 15737519
    [Abstract] [Full Text] [Related]

  • 17. Clinical comparison of cefuroxime axetil suspension and amoxicillin/clavulanate suspension in the treatment of pediatric patients with acute otitis media with effusion.
    Gooch WM, Blair E, Puopolo A, Paster Z, Schwartz RH, Miller HC, Smyre HL, Giguere GC, Collins JJ.
    Clin Ther; 1995 Mar; 17(5):838-51. PubMed ID: 8595636
    [Abstract] [Full Text] [Related]

  • 18. A multicenter trial comparing the efficacy and safety of cefuroxime axetil and cefaclor in pneumonia of adults.
    Yangco BG, Lowe J, Nolen TM, Schleupner C, Tan JS, Anthony W.
    Clin Ther; 1990 Mar; 12(5):440-6. PubMed ID: 2268867
    [Abstract] [Full Text] [Related]

  • 19. [Cephalosporin treatment of maxillary sinusitis].
    Köhler W, Schenk P.
    Laryngorhinootologie; 1995 Jun; 74(6):355-60. PubMed ID: 7662079
    [Abstract] [Full Text] [Related]

  • 20. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R.
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.